Stay updated on Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Sign up to get notified when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.

Latest updates to the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page
- CheckyesterdayChange DetectedPublications section updated to clarify that PubMed entries are auto-filled and may not be about the study; revision number updated from v3.2.0 to v3.3.1.SummaryDifference0.0%

- Check9 days agoChange DetectedThe Tainan location entry is updated from 'Tainan City, Taiwan, 704' to 'Tainan, Taiwan, 704' to reflect the corrected city designation.SummaryDifference0.2%

- Check16 days agoChange DetectedNo significant changes detected in the Study Details page for NCT04811092. The content and layout appear consistent with the registered record, including trial title, study design, and eligibility criteria.SummaryDifference0.0%

- Check23 days agoChange DetectedPublications section updated: added the NEJM paper 'Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis' (N Engl J Med. 2025 Oct 23; 393(16):1599-1611). The online-ahead-of-print listing dated Sep 30, 2025 was removed.SummaryDifference0.2%

- Check30 days agoChange DetectedTwo new study sites in Cali, Valle del Cauca Department, Colombia (760032) and (760042) were added, and the previously listed Santiago de Cali sites with those postal codes were removed.SummaryDifference0.0%

- Check37 days agoChange DetectedNo significant changes detected.SummaryDifference0.1%

Stay in the know with updates to Sotatercept in PAH: New Intermediate-High Risk Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sotatercept in PAH: New Intermediate-High Risk Clinical Trial page.